Lv4
610 积分 2024-06-28 加入
Allosteric inhibition of NMDA receptors by low dose ketamine
2天前
已关闭
Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management
4天前
已完结
Chapter Two - The Role of Orexin/Hypocretin in the Central Nervous System and Peripheral Tissues
6天前
已关闭
Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target
7天前
已完结
Comprehensive overview of novel chemical drugs for ulcerative colitis: focusing on phase 3 and beyond
7天前
已完结
The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases
14天前
已完结
Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activity
15天前
已完结
UNC93B1 variants promote SLE via TLR activation
15天前
已关闭
Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
19天前
已完结
皖公网安备34019202002308
